Policy Archives

News and Trends 19 Feb 2025

Trade war: how new U.S. tariffs will impact the biopharma industry

The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?

February 19, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 13 Dec 2024

Is China the future of biotech?

Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context.

December 13, 2024 - 12 minutesmins - By Jules Adam

In Depth 7 Mar 2024

Can AbbVie’s legacy live beyond its once best-selling drug Humira?

The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.

March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter

Expert Advice 1 Feb 2024

Corporate Sustainability Reporting Directive: Is the life sciences industry ready?

2024 will be the first year when biotechs will have to report on their sustainability data under the CSRD. But is the industry prepared?

February 1, 2024 - 10 minutesmins - By Jules Adam

In Depth 27 Nov 2023

How are R&D Tax Incentives shaping Australia’s biotech future?

Research and development (R&D) stands as a cornerstone for driving innovation, particularly within the biotech industry. The pivotal role of R&D extends beyond immediate commercial implications and encompasses a broader spectrum of societal and economic benefits. R&D represents significant expense, and if big companies can afford the risk, it may not be the case for […]

November 27, 2023 - 5 minutesmins - By Jules Adam

Cyberattack cybersecurity biotech startup

In Depth 25 Oct 2021

Biotech Startups Face a Growing Wave of Cyberattacks

The onset of the Covid-19 pandemic last year triggered a wave of cyberattacks in the life sciences industry, and the problem is likely to get worse. Biotech startups need to improve their cybersecurity, but where should they start? In January 2020, it was time to open the champagne for Andrew Sewell, Professor of Infection and […]

October 25, 2021 - 11 minutesmins - By Jonathan Smith

In Depth 3 Feb 2021

Detecting Gene-Edited Food: The EU’s Nightmare

The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The EU has some of the strictest food regulations in the world surrounding the cultivation and commercialization of genetically modified organisms (GMOs), which it defines as organisms whose […]

February 3, 2021 - 10 minutesmins - By Jonathan Smith

In Depth 7 Dec 2020

Are We Still Friends? What Brexit Means for UK Synthetic Biology

Synthetic biology is one of the big strengths of UK science, but can the country uphold its vantage point after Brexit, without the support of the EU? (Disclaimer: At the time of writing, no deal has been made between the UK and the EU following Brexit. This intrepid writer is an Irish citizen who made […]

December 7, 2020 - 8 minutesmins - By David Kirk

News and Trends 4 Dec 2020

EU Launches Pharma Strategy, Raising Both Hopes and Questions

The public’s response has been cautious after the European Union unveiled a pharmaceutical strategy last week designed to spur domestic innovation and the production of affordable, state-of-the-art therapies. Amid a boom in biotech funding driven by the Covid-19 pandemic, the European Commission (EC) is scrambling to bring its sometimes fragmented pharma regulatory framework up to […]

December 4, 2020 - 6 minutesmins - By Victor Kotsev

In Depth 11 Nov 2020

GMO Regulations in Europe Are “Not Fit for Purpose”

The controversial decision by the European courts in 2018 to regulate gene-edited organisms as GMOs has had a damaging effect on biotech companies working in this area. The current GMO regulations were established in Europe in 2001 and were designed to strictly regulate the introduction of DNA from other species into animals and plants. These […]

November 11, 2020 - 8 minutesmins - By Helen Albert

In Depth 5 Oct 2020

The Complications Around Patenting Biotechnology

Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field of intellectual property law: biotechnology patents. Back in 1873, microbiologist Louis Pasteur patented a new yeast-making […]

October 5, 2020 - 7 minutesmins - By External Contributor

Expert Advice 1 Jul 2020

Why Biotech Must Change its Cleaning and Disinfection Strategy

Many biotech companies deploy strong chemicals to clean and disinfect their equipment. However, if handled in the wrong way, this can lead to dangerous problems such as antibiotic resistance. As the EU prepares to release new guidelines on good manufacturing practices, it’s time to revise how cleaning is approached in the industry. To effectively control […]

July 1, 2020 - 10 minutesmins - By Melanie Maria Obermeier

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Policy

Trade war: how new U.S. tariffs will impact the biopharma industry

Is China the future of biotech?

Can AbbVie’s legacy live beyond its once best-selling drug Humira?

Corporate Sustainability Reporting Directive: Is the life sciences industry ready?

How are R&D Tax Incentives shaping Australia’s biotech future?

Biotech Startups Face a Growing Wave of Cyberattacks

Detecting Gene-Edited Food: The EU’s Nightmare

Are We Still Friends? What Brexit Means for UK Synthetic Biology

EU Launches Pharma Strategy, Raising Both Hopes and Questions

GMO Regulations in Europe Are “Not Fit for Purpose”

The Complications Around Patenting Biotechnology

Why Biotech Must Change its Cleaning and Disinfection Strategy

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!